3.0.0 5260 2023-03-08T20:26:22Z 2023-03-08T20:26:22Z House HR 2021-09-14 117 [Congressional Record Volume 167, Number 158 (Tuesday, September 14, 2021)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. PETERS:H.R. 5260.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3[Page H4524]]]> hsju00 Judiciary Committee House Standing hsju03 Courts, Intellectual Property, and the Internet Subcommittee Referred to 2022-11-01T19:56:52Z hsju05 Administrative State, Regulatory Reform, and Antitrust Subcommittee Referred to 2022-11-01T19:56:45Z Referred to 2021-09-14T15:02:25Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2021-09-15T18:35:36Z Referred to 2021-09-14T15:02:15Z hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2021-09-14T18:02:18Z Referred to 2021-09-14T15:02:20Z Freedom from Price Gouging Act 117 2706 HR 2021-04-21 Referred to the Subcommittee on Health. Related bill CRS Star Rating for Biosimilars Act 117 2855 HR 2021-04-27 Referred to the Subcommittee on Health. Related bill CRS Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 117 2873 HR 2021-09-29 Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 27 - 16. Related bill CRS Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act 117 2884 HR 2021-09-30 Ordered to be Reported in the Nature of a Substitute by Voice Vote. Related bill CRS Preserve Access to Affordable Generics and Biosimilars Act 117 2891 HR 2021-09-29 Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13. Related bill CRS Capping Drug Costs for Seniors Act of 2021 117 4417 HR 2021-07-14 Referred to the Subcommittee on Health. Related bill CRS Preserve Access to Affordable Generics and Biosimilars Act 117 1428 S 2021-12-09 Placed on Senate Legislative Calendar under General Orders. Calendar No. 180. Related bill CRS Affordable Prescriptions for Patients Act of 2021 117 1435 S 2021-07-29 Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably. Related bill CRS Seniors Prescription Drug Relief Act 117 2327 S 2021-07-13 Read twice and referred to the Committee on Finance. Related bill CRS Reduced Costs and Continued Cures Act of 2021 117 5237 HR 2022-11-01 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. Related bill CRS 2022-11-01 hsju03 Courts, Intellectual Property, and the Internet Subcommittee 1 House committee actions Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. Committee 2022-11-01 hsju05 Administrative State, Regulatory Reform, and Antitrust Subcommittee 1 House committee actions Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. Committee 2021-09-15 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2021-09-14 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2021-09-14 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2021-09-14 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2021-09-14 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2021-09-14 Introduced in House IntroReferral Intro-H 9 Library of Congress 2021-09-14 Introduced in House IntroReferral 1000 9 Library of Congress P000608 Rep. Peters, Scott H. [D-CA-52] Scott Peters D CA H. 52 N S001180 Rep. Schrader, Kurt [D-OR-5] Kurt Schrader D OR 5 2021-09-14 True R000602 Rep. Rice, Kathleen M. [D-NY-4] Kathleen Rice D NY M. 4 2021-09-14 True M001202 Rep. Murphy, Stephanie N. [D-FL-7] Stephanie Murphy D FL N. 7 2021-09-14 True C001110 Rep. Correa, J. Luis [D-CA-46] J. Correa D CA Luis 46 2021-09-14 True G000583 Rep. Gottheimer, Josh [D-NJ-5] Josh Gottheimer D NJ 5 2021-09-20 False Health Accounting and auditing Administrative law and regulatory procedures Administrative remedies Appropriations Civil actions and liability Competition and antitrust Congressional oversight Consumer affairs Contracts and agency Department of Health and Human Services Digestive and metabolic diseases Drug safety, medical device, and laboratory regulation Drug therapy Federal Trade Commission (FTC) Genetics Government studies and investigations Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Health technology, devices, supplies Home and outpatient care Inflation and prices Intellectual property Intergovernmental relations Judicial review and appeals Licensing and registrations Manufacturing Marketing and advertising Medicaid Medicare Performance measurement Prescription drugs Public contracts and procurement State and local government operations Health 00 2021-09-14 Introduced in House 2022-08-23T14:41:55Z Reduced Costs and Continued Cures Act

This bill establishes and alters several programs and requirements relating to the prices of prescription drugs.

For example, the bill establishes and alters several requirements under Medicare and Medicaid, including

  • requiring drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation,
  • capping annual out-of-pocket spending under the Medicare prescription drug benefit, and
  • increasing the maximum rebate amount under the Medicaid Drug Rebate Program.

The bill also makes changes relating to market exclusivities and manufacturer price concessions for prescription drugs, including

  • authorizing the Federal Trade Commission to initiate proceedings against parties to settlements of patent infringement claims that have anticompetitive effects with respect to drugs or biologics,
  • limiting in certain instances the number of patents that the manufacturer of a biologic can assert in a lawsuit against a company seeking to sell a biosimilar version, and
  • nullifying regulations relating to the treatment of certain Medicare prescription drug benefit rebates from drug manufacturers for purposes of federal anti-kickback laws.
]]> Reduced Costs and Continued Cures Act Official Title as Introduced To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. Introduced in House IH Display Title Reduced Costs and Continued Cures Act Short Title(s) as Introduced Reduced Costs and Continued Cures Act Introduced in House IH Introduced in House 2021-09-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117hr5260ih/xml/BILLS-117hr5260ih.xml 2022-11-01 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.